Completed
Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
NCT01598090
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- Birmingham Gastroenterology Associates, P.C. Birmingham, Alabama, United States
- The Kirklin Clinic Birmingham, Alabama, United States
- The University Of Alabama Of Birmingham Birmingham, Alabama, United States
- Anaheim Clinical Trials Llc Anaheim, California, United States